ARTICLE | Company News
Ivax, National Institutes of Health deal
January 8, 2001 8:00 AM UTC
IVX received an exclusive license from NIH to develop and market therapeutics that transport cytotoxic agents to brain cancer cells expressing the EGF receptor. ...